Mohammad Faheem Uddin1, Safa Ahmed1*, Sodadasu Kamala Vandana1, Dr. J. Raghu ram2, Dr. Mahaboob Khan3
1,2Pharm.D, Department of Pharmacy Practice, Sultan Ul Uloom College of Pharmacy, Hyderabad, Telangana, India.
3MBBS, MD Pulmonology, (Fccp-Usa), Government General and Chest Hospital, Telangana, India.
A B S T R A C T
Objective: To study the treatment outcome of tuberculosis and hiv co-infection including the various ADRs & Drug Interactions that occur during the co treatment of the disease with Anti tubercular drug and Anti-retroviral therapy. Method: An observational and active surveillance study was conducted in the Govt. general and chest hospital for over a period of six months. The information obtained was recorded in the data collection form and analyzed. Results: Descriptive statistical analysis have been carried out to generate the results. Results on categorical measurement are presented in (%). The results showed that the prevalence of ADR’s was about 84% and the drug interactions was found to be 73%.Conclusion:This highlighted the importance of developing strategies to amyliorated and drug drug interactions both to improve the quality of patient care and to control tuberculosis and HIV co-infection safely.
Key words: prevalence, HIV, adverse drug reaction, drug drug interaction